Dentsply Sirona (XRAY) Cash & Equivalents (2009 - 2026)

Dentsply Sirona (XRAY) has 18 years of Cash & Equivalents data on file, last reported at $190.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 52.26% year-over-year to $190.0 million; the trailing twelve-month figure through Mar 2026 stood at $190.0 million (down 52.26% YoY), and the FY2025 full-year result was $326.0 million, up 19.85% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $190.0 million, down from $326.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $418.0 million in Q3 2022 and bottomed at $190.0 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $326.0 million (2025), against an average of $326.4 million.
• The widest annual swing landed in 2022, when Cash & Equivalents soared 48.75%; it then slumped 52.26% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $365.0 million in 2022, then slipped by 8.49% to $334.0 million in 2023, then slipped by 18.56% to $272.0 million in 2024, then gained by 19.85% to $326.0 million in 2025, then tumbled by 41.72% to $190.0 million in 2026.
• The last three Cash & Equivalents figures came in at $190.0 million (Q1 2026), $326.0 million (Q4 2025), and $363.0 million (Q3 2025), per Business Quant data.

Peer Comparison